RDCA-DAP Webinar: Value of Integrated Data and Analytics in Rare Disease Drug Development

As part of The Rare Disease Cures Accelerator–Data and Analytics Platform (RDCA-DAP) webinar series on the use of rare disease person-level data in drug development and regulatory decision making, a webinar on the theme of Value of Integrated Data and Analytics in Rare Disease Drug Development is being organised.

The webinar will be held on June 16th from 18.00 – 19.00 CET.

Case Study: Modeling disease progression in polycystic kidney disease to inform trial design

Presenters: Rhoda Muse, Ph.D., Scientist 1, Quantitative Medicine; Klaus Romero, M.D., M.S., F.C.P., Chief Science Officer and Executive Director of Clinical Pharmacology; Jackson Burton, Ph.D., Executive Director, Quantitative Medicine

RDCA-DAP Team: Jeff Barrett, Ph.D., F.C.P., Senior Vice President, RDCA-DAP Lead; Alexandre Bétourné, PhD, PharmD, Scientific Director, RDCA-DAP

Target Audience: Industry, academic researchers and research-based nonprofit organisation leaders interested in understanding how rare-disease data can be applied to accelerate drug development for rare diseases and inform us on solutions to common drug development problems.

More information and registration here: https://criticalpathinstitute.cmail20.com/t/y-l-otruyjl-itikdhdrq-t/